GlassScriptPhysician profile
Evon Zoog
NPI 1265851505
$8,302.97
in general payments reported to CMS, 2019-2025
8 companies · $4,906 in 2025
The $4,906 reported for 2025 was more than what 97% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $44.07 · 2023: $67.19 · 2024: $3,286 · 2025: $4,906.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,674 · Honoraria: $2,400 · Travel and Lodging: $2,098 · Consulting Fee: $1,000 · Gift: $87.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,673.94 |
| Honoraria | $2,400.00 |
| Travel and Lodging | $2,097.96 |
| Consulting Fee | $1,000.00 |
| Gift | $87.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Motiva USA, LLC | $2,786.39 | 2025 | |
| Rti Surgical, INC | $2,400.00 | 2024 | Cortiva Allograft Dermis |
| Mentor Worldwide LLC | $1,869.27 | 2024-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Abbvie INC. | $1,068.07 | 2024-2025 | |
| Axogen | $67.98 | 2025 | |
| Stryker Corporation | $50.19 | 2023 | Universal Neuro 2 |
| Osteomed LLC | $44.07 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $17.00 | 2023 | Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Evon Zoog listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.